Cannabis Science Provides Update on Its “Trimcare

New Post Public Reply Private Reply Replies (0) Message Board

Jun 21, 2012 at 10:35 AM

Cannabis Science Provides Update on Its “Trimcare Brand” Acquisition
Print
Alert
Cannabis Science (OTCBB:CBIS)
Intraday Stock Chart
Today : Thursday 21 June 2012

Cannabis Science, Inc. (CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis-based products, is pleased to provide an update on its recent acquisition of the “Trimcare Brand”. Cannabis previously announced the acquisition on June 11, 2012.

Since that time, while further reviewing the agreements, both parties realized that due to some legal issues regarding licensing and ownership of certain assets the agreements need to be re-drafted.

The parties are currently working with the attorney’s on revising the finalized documents and once the documents are finalized, Cannabis will make its filings with the S.E.C. disclosing the acquisition.

Dr. Ivan Goldsmith has provided 20 years of professional service within the Las Vegas community. Trimcare has 5,000 active patients consisting of in and out of state patients, who are being treated by internal medicine, bariatrics, and anti-aging methods. Trimcare is a premier integrated weight loss and anti-aging clinic in Las Vegas. Also providing a number of additional services such as a “Physician Dispensing Pharmacy”. Cannabis Science comes together with Goldsmith Heath Care, in plans to expand the Trimcare line across the US in every major metropolis. These plans consist of opening up a second, third and fourth location in Las Vegas. Cannabis Science is currently in negotiations to open up the second clinic, in Henderson, Las Vegas. The first clinic already resides at 4240 West Flamingo Rd in Las Vegas and is 5,000 square feet.

Dr. Ivan Goldsmith and his staff will continue to work with Cannabis Science immensely. In addition to expanding operations, the Companies will combine their formulations along with medical cannabis to bring together a new line of products, ranging from all areas of medical and cosmetic needs. Trimcare is active in alternative delivery methods such as creams, pellets, patches, and transdermal skin delivery systems. Trimcare currently has 30 over-the-counter products on the market. Making up these product lines are supplements, skin care products, food, and hormone products. From inception, manufacturing, commercialization, relationships and products, Dr. Goldsmith has brought these 30 products to the market himself, and Cannabis Science plans to use his expertise and integrate them into its future line of products as well.

Cannabis Science will add many new additions to its team within its Executive Management, Scientific Advisory Board and Policy Advisory Board, including Trimcare employees, will have almost 30 staff members ranging from a wide variety of expertise.

For further information about Trimcare and Dr. Ivan Goldsmith, you can go to the Trimcare website, www.trimcare.com or read the previous news release on the Cannabis Science website www.cannabisscience.com, dated May 3, 2012 or click this link, http://www.cannabisscience.com/news-a-media/p...ystem.html.

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Worldline Crowned as 2026 SPARK Matrix Leader

Worldline's Journey to Leadership When you talk about the big dogs in payment services, Worldline’s name crops up for a reason. They've just snagged a top spot in the 2026 SPARK Matrix by the QKS Group, putting them in the limelight as a leader in Merchant Payment Platform technology. If you're in payments, this is worth a double take. The SPARK Matrix Breakdown The...

Beta Bionics Faces Class Action Over iLet Device Concerns

Securities Fraud Allegations Hit Beta Bionics Here's a fresh one on the market front—Beta Bionics is in hot water, and it's not looking pretty. The ticker NASDAQ:BBNX is swirling in the chaos of a class action lawsuit, thanks to a stock tumble that would make even seasoned traders cringe. What's got investors riled up? The nitty-gritty centers on accusations that the...

Franklin Financial Q3: 59% Net Income Surge Amid Growth

Soaring Net Income and Impressive Growth Franklin Financial Services Corporation (NASDAQ: FRAF) seems to be on a roll this year, painting a vivid picture of growth as they close out the third quarter of 2026. With a strong surge in net income—59.4% up from Q3 2025—this leadership in earnings is no fluke. Net Income and Earnings per Share Let's break it down: the...

Etisalat Surges: Net Profit Soars 46% Amid Growth

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Sands China Unveils $1B Senior Notes, Eyes Debt Maneuvering

A New Play in the Sands Well, here we go again with Las Vegas Sands (NYSE: LVS) putting together another financial puzzle. Sands China, their big performer over in Macao, is selling off $1 billion in senior unsecured notes. They're splitting it with $700 million at 6.400% due in 2032 and $300 million at a heftier 6.700% maturing in 2033. This feels like classic strategic...

Altitude+ and ViewLift Celebrate Record Fan Engagement

Fresh Off the Bench: Altitude+ Rises Picture this: you're cruising through October, watching the leaves fall and the puck drop, and here come Altitude+ and ViewLift boasting some record numbers. This ain't your everyday puff piece — they've got concrete results to back it up. Altitude+, charging into the 2026–27 NHL and NBA seasons, isn't just surviving; they're...

NJ's $21.3M Water Fix Fights PFAS, Boosts AWK

Water Woes Culminate in Triumph Alright, folks, you don't often see New Jersey in the headlines for anything groundbreaking in the right way, but here we are. The big news is a hefty $21.3 million project completion that finally puts some ammo against the notorious PFAS chemicals. If you've got any skin in the utility game or just a stake in clean water, this one's been...

Leadership Shake-Up at Equity LifeStyle Properties

Shifting Gears at the Top When the calendar flips to 2027, Equity LifeStyle Properties, Inc. (NYSE:ELS) will be kicking off the new year with a fresh lineup at the helm. After 13 long years steering the ship, Marguerite Nader is moving into the role of Executive Vice Chair of the Board of Directors, paving the way for Patrick Waite to step into her shoes as President and...

Kyungtz'e Eosan Sooryukje: Honoring Spirits and History

An Enchanting Ritual Comes to NYC Some things transcend the humdrum of everyday life, and right now, New York's set to witness exactly that. It's not every day you get treated to Korea's deep-rooted Buddhist traditions, but come November 13 and 14, that's precisely what's in store. The Korean Cultural Center New York (KCCNY) is bringing Kyungtz'e Eosan Sooryukje to the...

Strategic Resources Faces Board Shakeup, AGM Announced

A Shift in Strategic Resources' Boardroom Dynamics On days like these, companies aren't just ticking boxes. They're repositioning themselves for a future painted with a whole bunch of ‘what ifs’, and Strategic Resources Inc. is no exception. This isn’t just your run-of-the-mill board shuffle—Michael Moore’s resignation marks a pivot moment. Now, you might ask...